Erratum: MicroRNA‑218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 (Int J Mol Med 36: (93‑102) (2015) DOI: 10.3892/ijmm.2015.2216);MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1

International Journal of Molecular Medicine

Volumn 36, Issue 1, 2015, Pages 93-102

  Wang, Ting ^a   Chen, Tengfei ^a   Niu, Hua ^a   Li, Chang ^a   Xu, Chun ^a   Li, Yuanyuan ^a   Huang, Rui ^a   Zhao, Jun ^a   Wu, Shuyan ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

BMI1; Esophageal squamous cell carcinoma; Metastasis; MicroRNA 218; Proliferation

Indexed keywords

BMI1 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 218; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; APOPTOSIS REGULATORY PROTEIN; DNA BINDING PROTEIN; MAPK7 PROTEIN, HUMAN; MIRN218 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 7; TUMOR MARKER;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS METASTASIS; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; CELL MOTION; CELL TRANSFORMATION; CYTOLOGY; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; PATHOLOGY; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR INVASION;

3' UNTRANSLATED REGIONS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 7; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84930342533     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2023.5269     Document Type: Erratum

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Jemal A, Center MM, DeSantis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907, 2010.
3. Song Q, Liu H, Wang J, et al: Dinner-to-bed time and post-dinner walk: new potential independent factors in esophageal cancer development. J Cancer Res Clin Oncol 140: 817-821, 2014.
4. Wong TS, Man OY, Tsang CM, et al: MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. J Cancer Res Clin Oncol 137: 415-422, 2011.
5. Wang C, Wang X, Liang H, et al: miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCalpha. PLoS One 8: e73985, 2013.
6. Thulin P, Wei T, Werngren O, et al: MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor delta in human monocytes during the inflammatory response. Int J Mol Med 31: 1003-1010, 2013.
7. Ratner ES, Tuck D, Richter C, et al: MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol 118: 251-257, 2010.
8. Zhao BS, Liu SG, Wang TY, et al: Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev 14: 139-143, 2013.
9. Kinoshita T, Hanazawa T, Nohata N, et al: Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 3: 1386-1400, 2012.
10. Yamamoto N, Kinoshita T, Nohata N, et al: Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. Int J Oncol 42: 1523-1532, 2013.
11. Tatarano S, Chiyomaru T, Kawakami K, et al: miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 39: 13-21, 2011.
12. Uesugi A, Kozaki K, Tsuruta T, et al: The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 71: 5765-5778, 2011.
13. Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168, 1999.
14. Zheng F, Liao YJ, Cai MY, et al: The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289, 2012.
15. Tu Y, Gao X, Li G, et al: MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 73: 6046-6055, 2013.
16. Chen Z, Li J, Tian L, et al: MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma. Cancer Lett 350: 34-42, 2014.
17. Huang X, Lv W, Zhang JH and Lu DL: miR96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer. Int J Mol Med 34: 1599-1605, 2014.
18. Wang A, Landen NX, Meisgen F, et al: MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells. PloS One 9: e103206, 2014.
19. Alajez NM, Lenarduzzi M, Ito E, et al: MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 71: 2381-2391, 2011.
20. Tie J, Pan Y, Zhao L, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879, 2010.
21. He X, Dong Y, Wu CW, et al: MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 18: 1491-1498, 2012.
22. van der Lugt NM, Domen J, Linders K, et al: Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 protooncogene. Genes Dev 8: 757-769, 1994.
23. Vrzalikova K, Skarda J, Ehrmann J, et al: Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol 134: 1037-1042, 2008.
24. Gavrilescu MM, Todosi AM, Anitei MG, Filip B and Scripcariu V: Expression of bmi-1 protein in cervical, breast and ovarian cancer. Rev Med Chir Soc Med Nat Iasi 116: 1112-1117, 2012.
25. Wu Z, Wang Q, Wang L, et al: Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients. J Neurol Sci 335: 191-196, 2013.
26. Hamada S, Satoh K, Masamune A and Shimosegawa T: Regulators of epithelial mesenchymal transition in pancreatic cancer. Front Physiol 3: 254, 2012.
27. Paranjape AN, Balaji SA, Mandal T, Krushik EV, Nagaraj P, Mukherjee G and Rangarajan A: Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog. BMC Cancer 14: 785, 2014.
28. He Q, Liu Z, Zhao T, Zhao L, Zhou X and Wang A: Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma. Int J Biol Sci 11: 1-10, 2015.
29. Chen Y, Lian G, Zhang Q, Zeng L, Qian C, Chen S and Huang K: Overexpression of Bmi-1 induces the malignant transformation of gastric epithelial cells in vitro. Oncol Res 21: 33-41, 2013.
30. Xin T, Zhang FB, Sui GJ and Jin XM: Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity. Br J Biomed Sci 69: 62-66, 2012.
31. Peruzzi P, Bronisz A, Nowicki MO, et al: MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro Oncol 15: 1212-1224, 2013.
32. Guo S, Xu X, Tang Y, et al: miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Lett 344: 40-46, 2014.
33. Okumura T, Shimada Y, Moriyama M, et al: MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo. Int J Oncol 44: 1923-1932, 2014.
34. Kogo R, How C, Chaudary N, Bruce J, Shi W, Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget 6: 1090-1100, 2015.
35. Sui C, Xu F, Shen W, Geng L, Xie F, Dai B, Lu J, Zhang M and Yang J: Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET. Tumour Biol 36: 1511-1518, 2015.
36. Nishikawa R, Goto Y, Sakamoto S, Chiyomaru T, Enokida H, Kojima S, Kinoshita T, Yamamoto N, Nakagawa M, Naya Y, et al: Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Cancer Sci 105: 802-811, 2014.